XJPX
4031
Market cap58mUSD
Jul 10, Last price
1,068.00JPY
1D
0.75%
1Q
-14.83%
Jan 2017
-6.72%
Name
Katakura & Co-op Agri Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Katakura & Co-op Agri Corporation, founded in 1920 and headquartered in Tokyo, Japan, is a multifaceted enterprise with operations spanning agriculture, chemicals, cosmetics, animal feed, and real estate. The company's agricultural arm offers a wide array of products, including various chemical and blended fertilizers, sustainable organic and liquid fertilizers, microbial soil treatments, silica gel, home gardening supplies, and materials specifically designed for nurturing seedlings. Its chemical division supplies crucial feed ingredients such as calcium phosphate and calcium carbonate, alongside industrial, fertilizer, food-grade phosphoric, and sulfuric acids, as well as other liquid solutions and water. Beyond this, the firm provides essential raw materials for maintaining the health of livestock, encompassing poultry, pigs, dairy cows, and beef cattle. It also actively owns, manages, and operates a portfolio of real estate properties. In the cosmetic sector, Katakura & Co-op Agri develops, manufactures, and distributes key ingredients for skincare, haircare, and makeup products, featuring collagen, botanical extracts, and inorganic components like synthetic mica. Additionally, it undertakes contract manufacturing, specializing in freeze-dried cosmetic formulations. To further support agricultural practices, the corporation delivers a suite of analytical services, covering physical and chemical soil and compost assessments, biological analyses, quality evaluations for farm produce, cultivation trials, pesticide residue detection, and DNA analysis. The company's products are also distributed internationally through its export activities.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||